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Abstract
Cancer is a disease of cellular regulation, often initiated by genetic mutation within cells, and
leading to a heterogeneous cell population within tissues. In the competition for nutrients
and growth space within the tumors the phenotype of each cell determines its success.
Selection in this process is imposed by both the microenvironment (neighboring cells, extra-
cellular matrix, and diffusing substances), and the whole of the organism through for exam-
ple the blood supply. In this view, the development of tumor cells is in close interaction with
their increasingly changing environment: the more cells can change, the more their environ-
ment will change. Furthermore, instabilities are also introduced on the organism level: blood
supply can be blocked by increased tissue pressure or the tortuosity of the tumor-neovascu-
lar vessels. This coupling between cell, microenvironment, and organism results in behavior
that is hard to predict. Here we introduce a cell-based computational model to study the
effect of blood flow obstruction on the micro-evolution of cells within a cancerous tissue. We
demonstrate that stages of tumor development emerge naturally, without the need for
sequential mutation of specific genes. Secondly, we show that instabilities in blood supply
can impact the overall development of tumors and lead to the extinction of the dominant
aggressive phenotype, showing a clear distinction between the fitness at the cell level and
survival of the population. This provides new insights into potential side effects of recent
tumor vasculature normalization approaches.
Author summary
Multicellular organisms control their cells to facilitate higher level function of the whole
organism. In tumors, this control is lost and cells are allowed to enhance their fitness by,
for example, increased proliferation. Tumor cells continue to change their behavior
through accumulating mutations, leading to a complex and highly heterogeneous struc-
ture. Several computational studies have investigated the emergent structures of such
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mutating group of cells and led to the recognition that cellular heterogeneity within
tumors is essential to explain the observed morphologies. Most of these studies have con-
sidered a limited number of possible cell phenotypes, an isolated tumor cell population,
unlimited growth space around the tumor, often with an inexhaustible source of nutrients.
Here we introduce a modeling approach that takes into account the limited growth space
around the tumor, localized nutrient sources, cellular metabolism, and mutation in a con-
tinuous phenotype space. The model reproduces the Warburg effect due to the limited
nutrient supply leading to an irreversible switch in cellular metabolism, and, consistently
with previous models, exhibits stages of development together with a natural selection for
a rapidly growing phenotype. This phenotype locally emerges in stable environments, but
when nutrient supply becomes erratic, these show less resilience and are outcompeted by
slow growers.
Introduction
Cancer is a disease of multicellular regulation, in which malfunctioning cells can break free of
homeostatic regulations imposed by the host environment [1]. One of the main characteristics
of cancer is the increased proliferation and mutation of cancerous cells due to malfunctioning
control of growth and proliferation [1]. As these behavioral changes typically originate from
mutations in the cells’ genetic material, excessively proliferating cells accumulate further alter-
ations, leading to a possible amplification of malignancies. Traditional studies of altered cell
traits primarily focus on genetic mutations, but neglect the multicellular nature and genetic
variety of tumors.
Tumor heterogeneity has been demonstrated experimentally and is an active field of
research [2–4]. Neutral mutations may accumulate and contribute to intratumor heterogeneity
[5]. An intermediate level of heterogeneity is correlated with low survival probability [6]. Het-
erogeneity may even promote the collapse of tumor development by inducing a clone popula-
tion that supports and enhances the growth of other clones in mice [7]. Marusyk and
colleagues [7] claim that these supporter clones may be outcompeted by the more aggressive
subpopulation, leading to the disappearance of the supporters and to the consequent collapse
of the tumor. Heterogeneity questions the validity of previous whole–tumor analyses, as “the
most abundant cell type might not necessarily predict the properties of mixed populations”
[8], and emphasizes the need for more detailed approach.
Initial phases of tumor development are increasingly thought to give rise to a Darwinian
process [1, 9], where individual cells compete for growth space and nutrients. Selection is
imposed by the microenvironment, a highly complex entity spanning several ranges in size
from the endocrine regulation of the whole body down to the extracellular matrix (ECM) and
neighboring cells. During cancer development this environment is changed due to changes in
the cellular component, and due to the tissue and organism level reactions to the tumor.
Intrinsic coupling between neighboring cells forms the basis of the plasticity-reciprocity
model [10]: as cells alter their behavior (plasticity), their contribution to the local environment
changes through for example ECM remodeling, nutrient uptake, or adhesion molecule expres-
sion. In turn, the changed environment imposes an altered selection on the cells (reciprocity),
creating a feedback between cells and their local microenvironment. This cascading change in
behavior is reminiscent of the behavioral changes associated with stages of cancer development
[11] that was later described by the accumulation of mutations through which cells become
increasingly malignant [12]. Although a strict sequence of mutations was not found, a general
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pattern was observed in the majority of cases [12], linking the macroscopic stages to the cell-
level changes.
Computational modeling is an excellent tool for exploring, studying, and understanding
such complex systems, because it provides complete control over assumptions and reveal the
consequent behavior emerging from them. This allows the dissection of complex interactions
and exploration of experimentally challenging cases. A variety of models have been applied to
study cancer.
Using a population level description, Basanta and co-workers studied how the combination
of tumor treatments, p53 cancer vaccine and chemotherapy, can be optimized to yield the best
results [13]. In a similar study, Sreemati Datta and coworkers [14] model tumor development
with the inclusion of evolving mutation rates and show that the balance between inducing
driver mutations and mutation rates plays a key role in tumor growth: at high mutation rates,
genetic instability may counter tumor progression. Combined with close experimental verifi-
cation, Marusyk and colleagues [7] used a similar model to suggest that interactions among
clones may lead to an overall collapse of tumor development. This approach is able to incorpo-
rate evolutionary games to help cope with the development of treatment resistance. Such
space-free models assume that all cells within the tumor are able to interact with all other cells
directly, and are unable to deal with intra-tumor spatial heterogeneities.
Studies incorporating this spatial aspect have mostly worked with cellular automata (CA)
models. For example, Gerlee and colleagues were able to explain the ‘go or grow’ hypothesis
through the emergence of haptotaxis in their CA model [15]. In a recent study, Waclaw and
colleagues [16] used a CA model to show that cell motility together with cell turnover may pre-
vent intratumor heterogeneity. Of particular interest is the study of Anderson and colleagues
[17], where the evolution of a growing cell population and the effect of a heterogeneous envi-
ronment is explored. They represent the tumor environment as a distribution of ECM mole-
cules that together with oxygen serve as nutrient after degradation. Cell evolution is modeled
in the phenotype by selecting a set of cellular parameters (matrix degradation rate, prolifera-
tion rate, etc.) from a number of predefined phenotypes upon cell division. The new pheno-
type was either selected randomly or according to a predefined sequence progressing towards
more aggressive behavior. The authors found that cells evolved into a similar, aggressive phe-
notype when applying the random mutation scheme. Heterogeneity in the population was
found to give rise to irregular tumor surface, whereas environmental heterogeneity (heteroge-
neity in the ECM distribution) reduced population heterogeneity and favored the most aggres-
sive cell types. Low concentration of oxygen was also found to reduce population
heterogeneity and promote invasive finger formation; applying two bursts of oxygen in these
simulations led to the segregation of the mixed population. Similar models have been used to
show emergent progression of phenotypes related to hypoxia, glycolysis, and acid-resistance,
by including neuronal networks in cells [18], or angiogenesis by introducing blood vessels in
hypoxic regions [19]. Enderling and co-workers [20] introduced the cancer stem cell (CSC)
hypothesis in a similar model by incorporating cells with unlimited proliferation potential
(CSCs) and cells with limited proliferation potential. They found that cell death induced by
tumor therapy could lead to a more aggressive, proliferative tumor, as the CSCs were no longer
competing for space after the treatment. Using a combination model of phenotype evolution
and the CSC hypothesis, Sottoriva and colleagues showed that the presence of CSCs in the
model tumors led to more invasive tumor morphology [21]. The CA model further allowed
exploring efficient drug delivery through the neovasculature [22, 23], the role of spatial
arrangement of the vasculature in radiation therapy [24] and even the effect of the different 2D
representations of the 3D vasculature [25].
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Using a more detailed model allows to explore the evolution of many other aspects of cell
behavior, such as cell flexibility, cell adhesion, or cell shape. One such model used in tumor
modeling is the cellular Potts model [26, 27]. It has been used to describe, for example, the
effect of nutrient limitation on tumor growth morphology [28], or to compare the emergence
of distinct developmental stages in terms of morphology and growth in vascular versus avascu-
lar tumors [29]. Using a heterogeneous evolutionary model of CSCs, a recent study reported
the emergence of spatial stratification of tumors based on the evolution of adhesion molecule
expression [30]. A further line of models explore the effect of oxygenation of tumors [31] in
the light of chemotherapy [32]. An alternative way of introducing more detail is a spatial con-
tinuum representation of the cells. One example of this is the phase field method which has
been used in combination with discrete modeling elements to investigate tumor growth mor-
phology and its interaction with the vasculature [33, 34].
Most of the above models applies a sharp distinction between the tumor and the healthy tis-
sue. While the tumor is described in a cell-based detail, the environment is usually presented
as a continuum. These models implicitly assume that stromal cells surrounding the tumor do
not participate in the development of the tumor, and that these cells are fundamentally differ-
ent from the cancerous tissue. The transition between the stromal and cancerous cell states is
neglected. A recent exception from this is the work of Powathil and colleagues [35] where the
effect of irradiation on a small set of “healthy” bystander cells is investigated. As a result of irra-
diation and induced signals, stromal cells may apoptose or may be converted to the tumor cell
type in the model. However, in this and almost all of the above models the phenotypes avail-
able for evolving cells are restricted to a small, discrete subset of all possibilities. A continuous
range of cell states could reflect a more biological picture including more subtle, for example
epigenomic, changes. Furthermore, the nutrients are typically modeled as a single component,
however, one signature of cancerous cells is the reduced oxygen consumption and increased
glucose uptake. For this a more detailed nutrient description is required. Another less explored
point of interest is the change in the temporal behavior of the larger environment, the nutrient
supply. Initial tumors experience a stable blood supply in healthy tissues, that presents them
with a relatively constant environment. In contrast, angiogenic tumors at a later stage develop
neovasculature that is tortuous and leaky, presenting a fluctuating, unstable environment for
the cells [36, 37]. How does this temporal variation affect the population behavior? Would the
same aggressive phenotype dominate the population as in the stable environment, or would it
fit less than the less aggressive and stable phenotype?
Here we present a cellular Potts model of a closely packed, mutating cell population repre-
senting an epithelial tissue within an organism (Fig 1). Mutation in the model allows cellular
behaviors to vary continuously in a wide range of phenotype space, therefore evolution is gov-
erned by selection emerging naturally from the limitations of space, glucose, and oxygen. Cel-
lular metabolism is modeled as a mixture of aerobic glycolysis and respiration. Small scale
changes in the microenvironment are represented by the changes of the immediate cellular
neighborhood, both by mutations and cell rearrangements. We model large scale environmen-
tal fluctuations through the fluctuating activity of spatially fixed nutrient sources, which repre-
sent the cross-section of blood vessels.
Constructed in this way our model includes both the plasticity-reciprocity model of Friedl
and Alexander [10], as well as the large scale fluctuations imposed by the host. In the following
sections we analyze the behavior of the model with and without mutating cells. We show that
our model reproduces the Warburg shift, and exhibits stages of development similar to those
observed in previous studies (such as [17–19]). In our model cells undergo clonal expansion,
hypoxia, followed by starvation, with the development of segregated populations around blood
vessels. The spatial differentiation of cell populations is somewhat similar to the spatial
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diversity in real tumors as described by Alfarouk et al. [38]. Whereas Alfarouk and colleagues
describe two main habitat zones concentrically surrounding the blood vessel, we observe only
one of the zones with high proliferation rates and a robust cellular outflow from near the nutri-
ent source. Finally, our results indicate that the dominant aggressive phenotype is more sensi-
tive to fluctuations in the environment than the ones maintaining a stable phenotype without
mutation.
Results
Cellular Potts model of a homeostatic tissue
To investigate the above questions, we model a monolayer of cells using a modified cellular
Potts model (CPM) based on the CompuCell3D implementation [39] which can be obtained
from http://www.compucell3D.org. Customized code for the simulations and example param-
eter and initial condition files can be found in S1 File. In the following we give an overview of
the model; for more detail see the Methods section.
Cells in the CPM are represented as confluent domains on a lattice on which an integer
sð~xÞ at every position~x indicates which cell is occupying the location~x; cell-free areas are des-
ignated by sð~xÞ ¼ 0. Cell movement results from a series of elementary steps in which an
attempt is made to copy sð~xÞ at a randomly selected location~x to one of its randomly selected
neighboring location ~x0 . This attempt is accepted with a probability based on a Hamiltonian
goal function H that defines cell dynamics (Eqs 1 and 2). H is usually defined such that cells
maintain a controlled size, perform amoeboid-like cell movement, and may exhibit adhesion
or contact-repulsion. A time step in the model is defined as the Monte Carlo Step (MCS)
Fig 1. Illustration of model configurations and workflow of simulations. (a) Cells are initialized as a
monolayer with four endothelial cells (red) representing cross-section of blood vessels perpendicular to the
plane of simulation. (b) Simulation workflow. In the initial regime nutrients are allowed to diffuse into the
system to generate a steady-state distribution, during which cells metabolize without changing their size or
phenotype. After the fields have stabilized, the simulation is started and is run in iterative cycles of Monte
Carlo steps (MCS). After each MCS, each cell performs metabolic trafficking, and is probed for cell division.
Upon division, a potential mutation event is triggered in the daughter cells. Inset: unbiased parameters from
104 cells after t = 1, 5, 10, . . ., 5 × 104 number of mutations are distributed uniformly in the algorithm.
https://doi.org/10.1371/journal.pcbi.1005635.g001
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consisting of N elementary steps where N is the total number of lattice sites in the model. In
our model we apply the usual calibration by relating 1 MCS to 1 minute real time, and 1 lattice
site to 2 μm. Diffusion of soluble substances are simulated on a lattice identical to the cellular-
lattice. This calibration relates the simulated tissue area to 400μm × 400μm, and diffusion coef-
ficients of simulated nutrients to realistic values (glucose and lactate: Dg = 10−9 m2/s; oxygen:
DO2 ¼ Dl ¼ 10
  11m2=s) [40].
We implemented a metabolism whereby cells consume glucose and oxygen from their envi-
ronment and use a mixture of lactic acid fermentation and cellular respiration. Cells metabo-
lize oxygen and glucose to generate an abstract cellular energy that is used for their
maintenance and growth. The amount of energy required for cells is controlled by the expres-
sion levels of glucose transporters in the cell membrane which is determined by an intracellu-
lar growth signal parameter (N0(i, t) for cell i at time t). The mode of metabolism is
determined by an internal hypoxia inducible factor (h(i, t) for cell i at time t), that is controlled
through the oxygen levels inside and around the cell and the amount of intracellular reactive
oxygen species (ROS)(Eq 15). This factor determines the ratio of respiratory and fermentative
modes of cellular metabolism. In our model the speed of energy production, and hence cell
growth, is independent of the mode of metabolism in order to avoid a selection bias towards
the faster metabolic mode.
If a cell reaches a pre-defined doubling size it divides, hence cell cycle time is determined by
cell metabolism. Cell death may occur either due to starvation or age. If a cell generates less
energy from metabolism than is required for maintenance, it converts the necessary amount of
its cell mass into energy (catabolism). Once the cell mass is exhausted, the cell is considered
dead and is taken out of the simulation. Cells are also killed in the simulation with a 0.1% prob-
ability after each MCS to maintain cell turnover.
Glucose and oxygen are supplied by a separate set of designated immobilized cells that play
the role of blood capillaries (Fig 1a). To allow the temporal control of nutrient supply, capillar-
ies can be in an active or a blocked state. Nutrient levels are kept at a fixed concentration in the
blood stream, that is inside the capillaries, when the capillaries are active. When a capillary is
blocked, nutrient levels are kept at zero within the capillaries. The activity of the vessels are
changed with a probability (nutrient switching probability) after each MCS. A high switching
probability leads to a stable supply while a low switching probability results in an inconsistent
supply, mimicking blocked or tortuous vessels without affecting the average activity time of
the vessels. Lactate produced by cells as a waste from lactic acid fermentation is cleared out of
the system by active capillary cells.
For more detail on the model see the Methods section.
We start by first verifying that the model is capable of simulating a sustainable homeostatic
tissue. Therefore we studied the behavior of a healthy tissue in the absence of mutation and sta-
ble nutrient supplies. Fig 2a shows the model setup. We consider a two-dimensional square lat-
tice, corresponding with a slice of tissue of 400 μm × 400 μm (40 × 40 cells, 200 × 200 lattice
sites), containing four blood vessels arranged in a square formation (Fig 1a). To achieve con-
stant nutrient supply, the probability of a vessel to be blocked or unblocked in every MCS is
0.5. In this case each vessel switches between active (depicted in white) and blocked (depicted
in gray) states rapidly. As the nutrients diffuse away from the source, this rapid switching
results in a continuous supply of nutrients (Fig 2c). The color of tissue cells in Fig 2a indicates
the intracellular pressure, defined as the difference between target volume (biomass) and
actual volume of the cell (π(i, t) = VT(i, t) − V(i, t)). This measure differs from the extracellular
pressure as it includes any contribution of the contractile actin cortex surrounding biological
cells. Note that the pressure within the population is distributed without any specific pattern.
Blood vessel tortuosity and tumor evolution: A modeling approach
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Fig 2b shows the dynamics of the tissue for 105 MCS corresponding to approximately 70
days. The number of cells fluctuates around a constant value throughout the simulation
(Fig 2b), and is sufficient to cover the whole system: the ratio of the cell-covered region over
the total simulation area is close to one (Fig 2b). As the average intracellular pressure does not
increase over the course of the simulation (Fig 2b), cell growth and proliferation are kept in
balance with the basal metabolism and the constant cell turnover. Excessive growth is pre-
vented by the lack of growth space through a negative feedback between the intracellular pres-
sure and cell growth (Eq 18). Nutrient levels remain constant during the simulations and cells
remain respiratory as indicated by the absence of lactate (Fig 2d).
Model of tissue micro-evolution
Next we investigated how a cancerous tissue would behave in our model. Cancerous tissues
are characterized by large number of mutations, chromosomal rearrangements and changes in
gene expression level, all of which may result in phenotypic changes of the cells [1, 41–43]. To
mimic such changes, we allowed the set of 10 assigned phenotypic properties of cancerous
cells to change upon division (Fig 1b), including the division volume or adhesion parameters
(see Table 1 and Methods). After cell division, the daughter cells inherit the phenotypes of
their parents with some small mutations. Every parameter is allowed to change with a fixed
probability (mutation rate μp for parameter p) and independently of one another. The change
in parameter p is drawn from a normally distributed random variable with a standard
Fig 2. Simulations without mutations and with a stable nutrient source result in a stable tissue. (a)
Cell configuration at time t = 3000 MCS, showing pressure as color. Note the lack of any specific pattern in the
distribution of intracellular pressure. (b) The number of cells, and intracellular pressure stay relatively constant
in the course of the simulations. Cells cover approximately the whole of the tissue (coverage). Data averaged
from 10 independent simulation runs. (c) Nutrient distribution in the system happens via diffusion from active
blood vessels. The color codes the oxygen concentration in the system at t = 50,000 MCS. (d) Nutrient levels
stay constant in the system with abundant glucose, somewhat less oxygen, and no lactate. The absence of
lactate indicates that cells in the population remain respiratory.
https://doi.org/10.1371/journal.pcbi.1005635.g002
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deviation of σp, that is: p0 ¼ pþN ð0; spÞ. The parameters are allowed to change freely within
a pre-defined range (Table 1) with reflective boundary conditions. This allows an unbiased
parameter to uniformly explore the available range (Fig 1b inset).
To determine how a single mutating cell would perturb the homeostasis of the above tissue,
we inserted a cell with a mutation potential either near (Fig 3a, red cell) or far from (Fig 3b)
the nutrient source. The single mutating cell persisted in 28 and 26 simulations out of 100 for
the two different initiation positions. When the cell persisted, it expanded within the first 5000
MCSs and eventually colonized the population completely (Fig 3a and 3b).
In order to study the internal dynamics of the tumor, we will only focus on the case where
the mutating cell persists and has colonized the population; therefore we will initiate our simu-
lations with populations where all cells are allowed to mutate. Fig 3c–3f shows the behavior of
the model with mutating cell populations, with 10% mutation rate. In comparison with the
non-mutating populations, the intracellular pressure is higher (Fig 3c). This shows that cells
overcome the initial growth control mechanism. The number of cells initially increases,
reaches a peak, and then declines to approximately half of the peak value, well below the initial
numbers, where the population size stabilizes (Fig 3d). These changes in cell numbers are fol-
lowed by the intracellular pressure as well: in the expansion phase the pressure increases, but
before the peak in cell number it sharply declines. After the population size settles to a lower
value, the pressure settles to an approximately constant value. The full coverage of the tissue
drops to approximately half coverage, showing that the cancerous cells cannot maintain a com-
plete monolayer. Nutrients are depleted further from the blood vessels, resulting in a shortage
of oxygen in the distant regions (Fig 3e), shortly followed by the depletion of glucose (Fig 3f).
The depletion of oxygen triggers the cells to switch to fermentation, resulting in an increase in
lactate. This switch accelerates the depletion of glucose, causing the decline in population size.
After the population size is reduced, oxygen levels return to the same level as in the non-mutat-
ing populations, while cells still rely on fermentation as can be seen from the maintained lac-
tate levels (Fig 3f).
Emergent stages of development
Previous studies have reported distinct stages of development including hypoxia, glycolysis, or
acid-resistance [17–19]. However, in these studies the evolution occurred in isolation from the
stromal tissues and vasculature either using a limited set of phenotypic behaviors potentially
constraining the degree of freedom of the evolutionary trajectories or with immobile cells.
Table 1. List and values of mutating parameters in the model.
Parameter name Notation Initial value Step size Minimum value Maximum value
Incompressibility λv 25 0.2 0 20
Division volume VD 50 1 10 200
Cell adhesion ρCAM(cell) 99 0.1 0 100
Matrix adhesion ρMAM(cell) 49.5 0.1 0 50
Glucose chemotaxis χg 0 0.1 -20 20
Oxygen chemotaxis wO2 0 0.1 -20 20
Lactate chemotaxis χl 0 0.1 -20 20
Growth (see Eq 13) N0 250 25 0 2500
HIF threshold κh 0.1 10−3 10−4 10
ROS threshold κζ 0.5 0.01 10−4 100
https://doi.org/10.1371/journal.pcbi.1005635.t001
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Fig 3. Simulations with mutating cells and stable vasculature. Mutation rate = 10%. (a-b) Simulations
initiated with non-mutating cells (green) and a single mutating cell (red) near (a) or far from (b) the nutrient
source. The frames are from simulations where the mutating cell persisted and took over the population. (c-f)
Results from simulations initiated with mutating cells. (c) Cell configuration at time t = 3000 MCS, showing
intracellular pressure as the color code. Note the fluctuations in pressure distribution compared to the non-
mutating case in Fig 2. (d) Population dynamics of a mutating population as a function of simulation time,
showing the number of cells, intracellular pressure and tissue coverage. The number of cells initially increases
and after a peak drops to almost half of the peak value, where it stabilizes. The intracellular pressure follows
the initial increase in cell numbers. During the cell number drop the pressure is moderated to almost half, after
which it is increasing to reach a plateau. The tissue coverage drops from the initial full coverage to
approximately 50%. (e) Oxygen concentrations in the system at t = 3000 MCS. Nutrients are depleted further
from the blood vessels, eventually resulting in a shortage of oxygen in distant regions. (f) Nutrient levels
during the simulation reveal the depletion of glucose and oxygen during the expansion phase. A simultaneous
increase in lactate levels shows the appearance of fermentors. When nutrients are depleted, the population
size declines. With the decrease of respiration, oxygen levels return to the level observed in the non-mutating
populations (Fig 2d). Plots show average of 10 independent simulations.
https://doi.org/10.1371/journal.pcbi.1005635.g003
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Therefore, we first asked if stages of tumor progression also occurred in our less constrained
model. Fig 4 shows the behavior of our model with the nutrient concentrations and cell num-
bers averaged from 10 independent simulations with stable vasculature (switching probabil-
ity = 0.5) and 10% mutation rate. Based on this, we identified distinct stages in our model:
expansion (1), hypoxia (2), starvation (3). Insets show cell configurations characteristic of
the three stages, color scale on the insets indicates the oxygen concentrations. These stages
emerge as a result of an interplay between the cells and their environment, as in the proposed
plasticity-reciprocity hypothesis of Friedl and Alexander [10]. Stages in our model relate to: 1.
Conditioning the environment; 2. A reaction to the environmental change in the behavior of
cells (new phenotypes emerging, old phenotypes disappearing); 3. New environment created
by the new population. Remarkably, this shows that despite the much larger number and free-
dom of mutating parameters in our model, we still find the same phenomena of emergent
stages.
In the first stage of our model the population expands by cell growth and division. A high
intracellular growth signal N0 is selected for in the population, favoring fast growing cells
(Fig 4c). This parameter evolves much faster than any other of the 10 mutating parameters
(see also Table 1) while most of the other parameters do not exhibit such a strong and clear
drift by the end of the simulations (Fig 4d). Indeed, the overall behavior of the model did not
change qualitatively in simulations where only N0 or N0 and the chemotactic parameters are
allowed to evolve (S1 Fig). Since nutrients in the environment are not limiting due to the
assumed prior homeostasis, these cells simply outgrow the slower ones, creating patches of
high growth (Fig 4e). This leads to the expansion of fast growers, and as a result, cells from
newer generations appear in clumps of growth hot-spots (Fig 4f). At this stage expansion can
occur at any position in the population since nutrients are available at any location.
In the second stage of our model the population turns hypoxic. As the number of cells
grows, the intracellular pressure increases rapidly in the tightly packed tissue until about
t = 5000 MCS (see Fig 3d). At this time oxygen is depleted at areas further away from the
source (see Fig 4a middle inset at t = 6000 MCS). Fast growing cells (high N0, Fig 4g) are
unable to fuel their increased metabolic need through oxidative respiration and turn hypoxic
(Fig 4h). These cells further increase their glucose uptake (Fig 4i) due to the HIF1-α! GLUT
signaling pathway in our model (Eq 15), and start the production of lactate.
Finally, glucose is gradually depleted at regions far from the sources as a result of the ele-
vated glucose consumption rate of fast growing cells. In the depleted areas cells die out, and
with them the cell population is gradually decreased (Fig 3b and 3d). The only cells remaining
are around the vessels, that eventually hijack the source (Fig 4j and 4k). These cells continue to
compete as in stage 1, since the change in the environment near the vessels is minimal, and
keep increasing their internal growth signal from generation to generation (Fig 4j). Increasing
intracellular pressure near vessels (Fig 4k) exerted by neighboring cells and counteracts
growth.
Changes in nutrient levels indicate that our model selects for cells exhibiting the well-
known Warburg effect, whereby cells metabolize glucose through glycolysis even in the pres-
ence of oxygen (aerobic glycolysis) [44]. Cells in our model initially shift to aerobic glycolysis
to support their metabolic need escalated through competition, shown by the increasing levels
on intracellular hypoxia and ROS (Fig 4l). This results in an increase in extracellular oxygen
(Fig 4a). Despite the availability of oxygen, cells are unable to revert to a more efficient full
respiratory metabolism due to production of ROS which stabilizes HIF1−α and limits the
amount of metabolic flux through respiration (Eq 15), thus keeping it in a state of hypoxia in
our model (Fig 4l). Nevertheless, cells do consume oxygen but it is significantly lower than glu-
cose uptake (Fig 4m).
Blood vessel tortuosity and tumor evolution: A modeling approach
PLOS Computational Biology | https://doi.org/10.1371/journal.pcbi.1005635 July 17, 2017 10 / 32
Fig 4. Stages of development in simulations with mutating cells and stable vasculature. Mutation rate = 10%. (a) Number of cells and nutrient
levels as in Fig 3f, using a logarithmic time-scale with the three stages indicated with numbers. (b) Cell configurations of each stage with oxygen
concentrations color coded. (c) Population size (pink) and averages of all 10 evolving parameters scaled with their respective step sizes σp and
shifted to their initial values. Intracellular growth signal: N0. (d) Normalized parameter values at the end of the simulation runs (t = 105 MCS). (e-f)
Stage 1: expansion. Configuration of cells from a simulation showing the instantaneous growth rate (e) defined as the increase in target volume in the
current MCS, and generation age (f) at t = 2200 MCS. Patches of high growth appearing independently from the localization of sources. (g-i) Stage 2:
hypoxia. Configuration of cells from a simulation showing the intracellular growth signal N0 (g), level of hypoxia (h), and glucose uptake (i) at t = 6000
Blood vessel tortuosity and tumor evolution: A modeling approach
PLOS Computational Biology | https://doi.org/10.1371/journal.pcbi.1005635 July 17, 2017 11 / 32
Taken together, these results show that our model exhibits different stages of development
similar to previously published studies. Remarkably, this progression emerges in spite of an
almost completely unrestricted evolution of a large number of phenotypic parameters. Tumors
in this model are initialized at random positions, but due to the explicit representation of local-
ized nutrient sources, we show that they occupy the vicinity of blood vessels at later stages.
This is enhanced by the more realistic representation of cells in the CPM where cell shape and
compressibility allow cell rearrangements within the packed tissue as opposed to the more
rigid CA models exploring progression [17–19]. Secondly, we show that our model selects for
cells exhibiting the Warburg effect despite the lack of growth advantage of fermenting cells.
Higher mutation rate speeds up transition between stages
To test if the stages of tumor progression depend on the phenotypic mutation rates, we simu-
lated the model for a series of mutation rates. Whereas the non-mutating population keeps a
constant size, all mutating populations exhibit an initial increase in cell numbers (Fig 5a). In
highly mutating populations (5% and 10%) this increase is followed by a drop in cell numbers.
This drop is observed later in populations with 5% mutation rate, and population decrease is
just starting at the end of the simulations in populations with 1% mutation rate. Note that
the repetitions reproduce the behavior fairly well, suggesting the robustness of the system.
Therefore we suggest that similar stages occur at lower mutation rates, and the time needed
for reaching each stage depends on the mutation rate. This is supported by the changes in
nutrient levels in the simulations, which react faster to change than the total number of cells
(Fig 5b–5f). In healthy, non-mutating populations, nutrient levels and population size is stabi-
lized (Fig 2b). In mutating populations, cells evolve a higher metabolic demand in parallel with
increased proliferation. This results in an increase in population size and decrease in oxygen
levels, followed by a decrease in glucose levels. As oxygen becomes sparse, cells turn hypoxic
and switch from oxidative phosphorylation to aerobic glycolysis, resulting in an increase in
lactate levels. We have found the same behavior in populations with different mutational prob-
abilities ranging from 0.1% up to 10% (Fig 5b–5f), or higher (S2a–S2h Fig). Again, a lower
mutational probability only delayed the changes in the nutrient levels. We did not find a quali-
tative difference in the progression in our simulations at different mutation rates, showing that
the emergent order of stages is robust in this system.
To explore the structure of the population at different mutation rates in the system, we
analyzed the distribution of cells in the space of normalized mutating parameters. After sub-
traction of the initial parameter values and normalizing with mutational step-size, the ten-
dimensional parameter space of the population was reduced to the three most prominently
changing axes within each population using principal component analysis (see Methods).
Fig 5g shows one example population at the final time point of the simulations for mutation
rates 1%, 10%, and 20% with each dot representing a cell. At low mutation rate (1%) the popu-
lation splits up into well-defined clones which are more spread and less well-defined at higher
mutation rates. The first three principal axes contain most of the information about the shape
of the population, as can be seen by the normalized weights (eigenvalues) of these components
(Fig 5h). The composition of principal axes at the final time point of the simulations shown on
Fig 5g differ (Fig 5i) with the growth signal N0, cell rigidity λV, and glucose chemotaxis χg
MCS. (j-k) Stage 3: starvation. Configurations of cells from a simulation showing growth rates (j) and intracellular pressure (k) at late stages of
development. (l-m) Evolution of cellular metabolism showing intracellular hypoxia and ROS (l) and nutrient uptake (m). Line graphs show average of
10 independent simulations with standard deviation, box plots show median with interquartile range and minimum / maximum values from 10
independent simulations.
https://doi.org/10.1371/journal.pcbi.1005635.g004
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Fig 5. Effect of mutation rate on population size and stage progression. (a) Number of cells in the population as a function of
time. (b-f) Nutrient levels in simulations with mutation rates 0.1% (b), 0.5% (c), 1% (d), 5% (e), and 10% (f) showing a similar behavior
in all cases. (g) Distribution of cells along the three main principal components of the populations in phenotype space from example
simulations with 1%, 10%, and 20% mutation rates at the end of simulations (t = 105 MCS). Each dot represents a single cell. (h)
Relative weight (eigenvalues) of the principal axes of the populations shown in (g). (i) Composition of the first three principal axes in
the populations shown in (g). (j-k) Spread and density of clusters identified in phenotype space at the end of simulations using
hierarchical clustering, depicted as the function of distance from the origin. Each dot corresponds to one cluster from a total of 10
independent simulations. (l-m) Spread and density of clusters throughout the evolution of the model. Data from 10 independent
simulation repeats from each condition, except (g-i) which shows data from one simulation from each condition.
https://doi.org/10.1371/journal.pcbi.1005635.g005
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playing an important role at μ = 1%. At 10% mutation rate the lactate chemotaxis parameter χl
plays a distinct role in segregating the population phenotypes, while at μ = 20% the segregation
is less obvious (Fig 5g) and is driven mainly by parameters λV, doubling volume VD, and adhe-
sions (ρCAM, ρMAM). While the composition of the main axes varies across different simulation
repeats with the same mutation rate, the populations are nevertheless well characterized by the
first three components in all cases (S2i and S2j Fig).
To better understand population structure in the simulations, we categorized the cells at
each time point in the 10-D phenotype space using hierarchical clustering (Methods). We
measured the displacement of each cluster as the Euclidean distance between the point of ori-
gin and its center of mass and its spread as the mean distance of points of the cluster from the
cluster’s center of mass. As expected, we observed that populations with higher mutation rates
reach further from the origin by the end of simulations; these clusters are more spread and less
dense than clusters in populations with lower mutation rates (Fig 5j and 5k). Considering the
whole time course of the simulation, the cluster analysis reveals that as the population explores
the phenotype space, clusters from the highly mutating populations first tend to spread out
and dilute more than the clusters in populations from lower mutation rates (Fig 5l and 5m).
These results show that the population starts to dilute much faster in phenotype space at high
mutation rates, but without affecting the progression of stages apparent from the nutrient
levels.
Faster growing cell population is less robust in the face of external
nutrient fluctuations
Next, we tested how feedback from a larger spatial organizational level, through the nutrient
supply in our case, would affect populations of different mutation rates. In a healthy tissue,
nutrient supply is relatively constant. The main source of fluctuations are the slow daily change
according to the circadian rhythm, and the relatively fast blood pulse. In cancerous tissues the
vasculature is remodeled through tumor vasculogenesis, resulting in tortuous and leaky vessels
[36, 37]. As these vessels are less reliable, here we assume that they dysfunction from time to
time, for example by becoming temporarily blocked.
To model vessel tortuosity, we introduced a blocking probability for the vessels. An open
blood vessel will be blocked with a probability P at every time step, and a blocked vessel will be
opened with the same probability. A high blocking probability (P ¼ 0:5) corresponds to a
healthy situation, where the resulting fast switching of the vessel is smoothened out by nutrient
diffusion. A lower blocking probability introduces longer periods of nutrient deprivation but
also longer periods of nutrient supply. On average these systems receive the same amount of
nutrients, but in different dosage.
Healthy, non-mutating populations in our simulations survived over a wide range of nutri-
ent fluctuations. The average number of cells from 10 simulation repeats showed that these
populations keep roughly the same size at different blocking probabilities, as shown on Fig 6a.
At the extreme blocking probability P ¼ 0:001, only 2 out of 10 populations died out.
In comparison, mutating cell populations are unable to tolerate blocking probabilities
lower than P ¼ 0:01, irrespective of their mutation rate (Fig 6a). Note that at high P, popula-
tions with low mutation rates have an increased population size at the end of the simulations
(t = 105 MCS), compared to the healthy population. This increase results from the initial stage
of progression, as these populations only reach the first stage (expansion) by the end of the
simulations. However, this advantage disappears as P decreases.
The observed reduction in population size due to decreasing P could work in two ways:
either by killing cells through starvation, or by speeding up the progression of stages. In the
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previous section we showed that a higher mutation rate speeds up the progression of the popu-
lation and thus results in a reduced population size (Fig 5). This might eventually lead to
extinction. If the populations under fluctuating nutrient supply go through the same stages of
progression as the ones in the stable environment, the environmental indicators used in Fig 5
(levels of glucose, oxygen, lactate) are unsuitable, as these might change in simulations with
different P. Instead, we focus on the intracellular evolution of traits, that are not altered
directly in these experiments. The first trait to be selected for is the intracellular growth signal
of the cells (N0(i, t)) that exhibits a run-away dynamics (Fig 4c). If the blocking probability
accelerates the progression through the stages, it should increase the selection pressure on the
intracellular growth signal as well. Contrary to this expectation, we found that the trend in
the average value of the intracellular growth signal remains approximately the same in simula-
tions across different P values, and even slightly decreases at lower P (Fig 6b). Similarly, other
cellular measures (such as hypoxia, ROS, or pressure), or cellular parameters (such as the
Fig 6. Effect of fluctuating nutrient supplies on the tissue. (a) Number of cells at the end of simulations
(t = 100,000 MCS), showing for simulations with different vessel tortuosities (P) and different cell mutation
rates (μ). In simulations with healthy vessels (high switching probability P) a mutating cell population produces
more cells than non-mutating ones. However, in simulations with erratic nutrient supply (with lower blocking
probability P), the mutating populations die out more frequently than the non-mutating ones. At extreme
erratic switching (P ¼ 0:001) 10 out of 10 mutating populations are extinct and even healthy ones start to die
out (2 out of 10 simulations). Error bars indicate standard deviation of cell numbers from 10 repetitions. Values
belonging to different simulations with the same mutation rate are connected and are slightly shifted on the x-
axis for better visibility. (b) Average intracellular growth signal evolution in the population are not changed in
simulations with different vessel blocking probabilities (mutation rate μ = 0.1%). This shows that the vessel
blocking probability does not directly affect selection and progression speed. (c) The average intracellular
growth signal in simulations with decreasing vessel blocking probability (P ¼ PðtÞ, solid lines) in mutating
(red, μ = 10%) and not mutating (blue, μ = 0%) populations. Cell-cell competition in mutating populations
initially drives the growth parameters to a high value just as in the simulations with stable nutrient sources.
When the blocking probability reaches the magnitude of PðtÞ ¼ 0:01 and below, populations die out (dashed
lines: percentage of simulations with living cells). (d) Population sizes in simulations with stable nutrient
sources (P ¼ 0:5) and in simulations where the blocking probability is controlled by the cell density
(P ¼ PðrÞ), creating a feedback. In both cases the populations survive. The tissue coverage is approximately
halved, making the vessel blocking probability approximately P ¼ 0:27 in the feedback simulations.
https://doi.org/10.1371/journal.pcbi.1005635.g006
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chemotaxis parameters) show the same behaviors irrespective of P (S3 Fig). Therefore, longer
nutrient fluctuations do not accelerate the evolution of the population, and the reduction in
population size is not a result of the acceleration of the same evolutionary dynamics. Instead
we conclude that as cells deplete the nutrients in the environment due to their increased con-
sumption, the chance for survival in systems with longer fluctuations is reduced.
Next we altered P during the time of simulation runs. We tested how the population
reacts if the blood vessels become increasingly tortuous, starting from a healthy state (fast
switching) progressing to a tortuous vasculature (slow switching). Blocking probability in
these simulations is decreased gradually in the simulations, following a geometric progression
Pðt þ 1Þ ¼ rPðtÞ with an initial value of Pðt ¼ 0Þ ¼ 0:5 and ratio of r = 0.999876. Once the
progression reaches Pðtf Þ ¼ 0:001 at tf 50,100 MCS the blocking probability is not
decreased further (Pðt > tf Þ ¼ Pðtf Þ). Similar to the stable system, the mutating populations
(mutation rate μ = 0.1) are initially driven into the high consumer state by cell-cell competition
(Fig 6c solid red line showing growth signal parameter N0). When the fluctuation probability
reaches the order of PðtÞ ¼ 0:01 (t 31,500 MCS), the populations start to die out (Fig 6c red
dashed line showing number of surviving populations), similar to the case of static low block-
ing probabilities. Note however, that non-mutating populations (Fig 6c blue) are able to sur-
vive increasing fluctuations in the nutrient supply. This shows that a changing nutrient supply
does not necessarily influence the direct competition among cells.
Inconsistency of nutrients may emerge from the dysfunctional tissues of the emergent
tumor occluding vasculature. To represent this feedback, we examined how the population
behaves when the consistency of nutrient supply is related to the amount of cellular coverage
in the tissue. We created a feedback between the density of the tissue (measured as tissue sur-
face coverage ρ, with 0 ρ 1) and the fluctuating source. For a fully populated tissue we
kept the nutrient switching probability high, P ¼ 0:5, providing a smooth nutrient supply,
and decreased it linearly with the cell density to model the variability in nutrient supply. Thus:
PðrÞ ¼ 0:499rþ 0:001. In these simulations the mutating population persists at approxi-
mately the same level as in the healthy case (Fig 6d). The emergent tissue coverage yields an
approximate fluctuation probability of PðrÞ  0:27, sufficiently high to support mutating
populations. While the relationship between nutrient supply stability and living cell density is
experimentally unclear, our results suggest that a linear relationship between stability and den-
sity is insufficient to drive the aggressive cells to extinction, similar to what is expected of an
expanding pathological tumor.
The effect of low nutrient levels with two consecutive surges of high oxygen levels has been
shown to affect selection in a model of evolutionary tumor growth [17]. Here we used localized
nutrient sources and stochastic supply, rather than two deterministic and uniform pulses. We
show that in our system, inconsistent nutrient supply does not increase the speed of cellular
evolution, however, it does reduce the viability of the unstable cell populations. We found sim-
ilar results when inconsistency is considered progressively increasing or proportional to the
tissue coverage. Our results suggest that, while consistent nutrient supply promotes cell-level
selection of fast growing cells, inconsistent nutrient supplies that put a larger demand on the
tissue exert selection at the tissue scale and provide higher chances of survival for populations
with cellular quiescence.
Clonal expansion and heterogeneity as a consequence of differential
growth
In a simulated healthy tissue devoid of mutants, cell growth is independent of spatial localiza-
tion, growth is limited intrinsically by a constant growth signal balancing spatial confinement.
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After this intrinsic limitation is lifted through uncontrolled mutations and competition,
growth becomes clustered in growth hot-spots (Fig 4e). These spots are populated by overly
proliferative cells, resulting in clonal expansion: Fig 7a shows configurations at two time points
in the same simulation color-coded for descendants. At a later stage, when cells deplete nutri-
ents, proximity to the sources dictates the growth rate (Fig 4j). In the resulting environment
cells closer to the source grow faster and divide, while cells further away starve and die. This
differential growth gives rise to a directed cell movement from the vicinity of the sources to the
Fig 7. Clonal segregation. (a) Clonal expansion. Model configurations of the same population at t = 1500 MCS and t = 6000 MCS. Each
cell is depicted with one of 256 different colors at time t = 1500 MCS, and the daughters inherit this color from that time point onwards.
The population 4500 MCS later consists of the descendants of about a dozen of the initial cells. (b) Cell trajectories showing that cells
flow outwards from the nutrient sources (indicated with black dots). (c) Trajectories from a setup with randomly placed vessels, showing
that the outflow is determined by the placement of vessels. (d) The population segregates into independently evolving parts around the
blood vessels. Color code shows the chemotaxis parameter for glucose (χg(i, t)) and the stiffness parameter λv(i, t) at t = 70 000 MCS.
Cells around the same source are homogeneous, but are different from cells surrounding other sources. (e) Chemotaxis parameter
(χg(i, t)) and stiffness parameter (λv(i, t)) values in the populations shown in (d) as the function of time. The four segregated parts clearly
separate in their parameter values, and evolve almost independently. Vertical line denotes the time t = 70 000 MCS corresponding to the
time of the configurations on (d). (e) Trajectories from a late population in the fluctuating system, showing the trajectories moving from
one source to another. Movement direction is indicated with arrows. (g, h): Combined chemotaxis parameters (hχ0(i, t)ii = hχg(i, t) +
χo(i, t) − χl(i, t)ii) as a function of time in simulations with different vessel tortuosities at the first 20 000 MCS (g) and for the whole
simulation time (h). The parameter is increasing in all simulation conditions, showing that nutrient detection is important for cell survival.
In simulations with lower blocking probabilities the random selection introduced by the blocking and opening of the vessels results in a
higher noise in the combined chemotaxis parameters average. Values averaged from 10 independent simulation runs for each condition.
https://doi.org/10.1371/journal.pcbi.1005635.g007
Blood vessel tortuosity and tumor evolution: A modeling approach
PLOS Computational Biology | https://doi.org/10.1371/journal.pcbi.1005635 July 17, 2017 17 / 32
depleted areas, apparent from the short cell trajectories shown in Fig 7b. To demonstrate that
the segregation patterns were indeed linked to the nutrient sources and are not the result of
finite system size, we performed simulations with randomly scattered blood vessels instead of
the regular distribution, similar to previous studies [24, 31]. The example trajectory plot on
Fig 7c shows that the outflow of cells is correlated with the nutrient positions.
The population becomes segregated, as the probability of a cell invading a neighboring
region is diminished. As a result of this differential growth cells near the source take over the
vicinity of the vessel and spread their phenotype in this region (Fig 7d). While cells within
each segregated part of the population have highly similar phenotype, the different parts
evolve independently of one another. This is shown by the distribution of phenotypic traits
over time in each population (Fig 7e). This gives rise to independently evolving quasi-species-
like populations within the tissue, and might be analogous to the observed heterogeneity in
tumors.
In simulations with low but constant vessel blocking probabilities cells around a blocked
source are able to leave their region and migrate to another active source, as exemplified by the
trajectories in Fig 7e. The ability to detect and to move to a neighboring active source is crucial
for the cells for survival, and therefore is expected to be selected for. In our model, cells can
achieve this by evolving chemotaxis towards glucose or oxygen, or chemotaxis away from lac-
tate. Indeed, chemotaxis parameters are the second most affected parameters throughout the
evolution of the population (Fig 4c and 4d). Interestingly, chemorepulsion by lactate is
strongly selected for although lactate in our model does not have any direct metabolic effect on
the cells. This acquired property helps to orient the cells towards the nutrient sources better
than oxygen, which becomes ubiquitous with more shallow gradients, or glucose, which does
not diffuse far from the nutrient sources due to elevated uptake. The sum effect of these motil-
ity parameters can be expressed with a combined chemotaxis parameter defined as:
w0ði; tÞ ¼ wgði; tÞ þ wO2ði; tÞ   wlði; tÞ. Fig 7g and 7h show the evolution of this combined che-
motaxis parameter in populations from different vessel blocking probabilities and mutation
rate of 10%. Indeed in all of the conditions the combined chemotaxis is selected for. In simula-
tions with lower blocking probabilities the combined chemotaxis has increasingly higher fluc-
tuations due to the random selection introduced by the blocking and opening of the vessels,
often leading to extinction as well.
Discussion
In this study we introduced a computational model to explore the evolution of tissue cells
under specific conditions. Selection in the model acts through physical constraints: limited
growth space, and limited nutrient diffusion. Selected cellular phenotype traits, such as cell
rigidity or growth signal, are allowed to change (“mutate”) upon cell division in any direction
with a probability within a given range.
Progression of phenotypes
We show that a directional evolution emerges from random movement in phenotype space as
the result of cell competition, driving cells from a healthy (homeostatic) state to a more aggres-
sively expansive phenotype. This is consistent with previous findings of Anderson and col-
leagues [17], who showed that a similar drift towards aggressive phenotypes emerges if cells
are allowed to mutate randomly into one of a 100 predefined discreet phenotypes. In contrast
to these abrupt changes in behavior, our model only allows small changes in mutation. This
choice lends more persistence to the clones in the population, since more mutation events are
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required to diverge from an existing clone. Faster growing cells are selected in our model,
which then go on to colonize the population by means of clonal expansion.
Progression of phenotypes has been observed previously in other models of tumor evolu-
tion, where the authors also considered the toxic effect of acidification due to glycolysis
[18, 19]. In [18], cells first develop the ability to survive in hypoxic environments by lowering
their apoptotic response threshold to low oxygen levels. This is followed by a metabolic switch
to glycolysis and finally the emergence of the acid-resistant phenotype. In contrast, acid-
resistance was proposed to emerge first followed by evolution of glycolysis in another model
where nutrient sources were represented as point sources [19]. The distinct stages exhibited in
our model (clonal expansion, oxygen depletion, and starvation) are accompanied by a sudden
increase in glycolytic activity which is then moderated onto a stable medium level (Fig 4l). In
our model the population turns hypoxic (Fig 4l) before developing a distinct chemo-repulsive
response (Fig 4c). We found the progression robust against changing the mutation rate, how-
ever, at higher mutation rates the population was able to explore the phenotype space faster
and in more dispersed clusters (Fig 5).
Although lactate in our model does not affect cells, cells gradually develop a chemorepul-
sion away from lactate (a negative χl on Fig 4c and 4d). Lactate accumulates at regions where
high consumers deplete glucose, therefore cells use lactate chemorepulsion as a compass to
navigate away from the high-consumer niche towards a more supportive environment. This
novel feature in our model highlights how phenotypes that show no apparent advantage at the
cell level could be selected for based on the altered micro-environmental conditions.
Minor differences in proliferation lead to clonal expansion
Local expansion in tumor growth models has recently been described by Waclaw and col-
leagues [16]. Their study focused on heterogeneity in passenger mutations while the proba-
bilistically occurring driver mutations set the proliferation advantage. Cell motility there acts
to blur intratumor heterogeneity by allowing proliferating cells to invade ‘cell-free’ areas where
further proliferation is not inhibited by other cancer cells. While this model is able to repro-
duce the clonal expansion features of tumors, it neglects the potential inhibitory effect of spa-
tial constraint produced by the surrounding stromal tissue. Proliferation diversity in tumors
was shown to be essential to explain experimentally observed tumor morphology by an earlier
study using the cancer stem cell hypothesis [20] which interprets the tumor as a conglomerate
of self-metastases. The emergent clonal expansion patterns in our model (Fig 7a) are reminis-
cent of these self-metastases and therefore suggest that slight differences of proliferation rates
within the population are sufficient to generate these patterns, as opposed to the sharp distinc-
tion between cancer stem cells and non-stem cells.
Spatial confinement and localized nutrient sources
Previous models of tumor evolution typically neglect the confining effect of the surrounding
healthy tissue although spatial confinement can play an important role when studying the
effects of treatment recovery in a tumor with a cancer stem cell population [21]. When a large
portion of cells is killed by therapy, the internal cells have access to growth space and are able
to regrow the tumor. In other words: space limitation keeps the growth inhibited. To mimic
this situation here we restrict the growing tumor to a confined space, making them a model of
an in vivo system. We note that simulations in our system do not develop a necrotic core as in
other models, as dead cells simply shrink and disappear from the simulations without inducing
any signaling response from neighboring cells or without increasing spatial confinement.
Therefore our system focuses on live tumor cell evolution where necrotic cells may be
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considered as extruded from the simulated monolayer region into the underlying necrotic
core, removed by the immune response and/or drained by the lymphatics.
The source of nutrients in previous models is typically considered uniform, or is provided
in the environment in a dispersed fashion. The source of nutrients are the blood vessels in our
model, similar to the more recent studies of Shirinifard and colleagues [29], Powathil and
coworkers [31, 32, 35], or Patel and colleagues using a hybrid cellular automaton model [45].
Two recent studies showed that arrangement of vessels and their 2D representation affects tis-
sue oxygenation and may alter the outcome of a simulated radiotherapy [24, 25]. Nutrient dif-
fusion and utilization create a spatial gradient in the supplies which is translated into a
differential growth pattern in our system. Differential growth creates a collective flow of cells
outwards from the sources (Fig 7b, 7c and 7f). This outward flow is counter-acted by the
emergent chemotactic tendency of cells to move closer to the source (Fig 4c and 4d). Chemo-
taxis in a changing environment provides additional advantage in locating active nutrient
sources (Fig 7f).
Blood vessels in our model are immobilized entities, vascular remodeling is not included.
Inconsistency in nutrient supply is implemented as stochastic switching of blood vessel activ-
ity, but without feedback from the pressure or hypoxia in the tissue as in the phase field model
of Yan and colleagues [34]. Simulations where the blocking probability P is a function of time
(Fig 6c) or tissue coverage (Fig 6d) showed that the progression of stages is not altered in our
system. A higher number of connected loops have been shown to emerge in 3D models of
tumor angiogenesis than in 2D, predicting that complete blockage of circulation is very rare
[22, 23]. Here we studied local vessel blockage which would still have a local effect on our sys-
tem, even if at a reduced frequency.
Inconsistent nutrient supply
Previously Anderson and colleagues showed that surges of oxygen induce diversification into a
population of simulated cells evolving under low oxygen levels [17]. A repeated, second surge
was shown to induce phenotypic segregation in these simulations [17]. Here we studied how
inconsistency of the nutrient supply affects the population using stochastic (rather than deter-
ministic) switching. In contrast to Anderson’s study, cells do not receive a constant low oxygen
supply in our model and are therefore prone to extinction. We found that populations with
increasing mutation rate are increasingly sensitive to nutrient fluctuations (Fig 6a), although
the evolutionary trend at the cell level remained largely unaffected (Fig 6b, S3 Fig). In our
model the aggressive phenotype analogous to cancer is a natural consequence of selection on
the cell-level and random mutation. When selection pressure is applied on the tissue level (in
the form of fluctuating nutrient supplies) the overall fitness (or survival) of the cancerous pop-
ulation proves to be lower than that of the healthy population, potentially due to depletion of
ambient nutrient resources as a form of competition. Cancerous cells create an insecure envi-
ronment that is more sensitive to stress coming from outside the cell population.
This theoretical exploratory study opens questions in how to best approach normalization
of the tumor vasculature. In the model, healthy cells are able to withstand the irregularities in
nutrient supply better than cancerous cells. Based on this observation, it is tempting to specu-
late that irregularities of the tortuous tumor vasculature might serve a similar role in real
tumor development. It is important to bear in mind that these results are based on a rudimen-
tary model of tumor development. In addition to the simplifications discussed above, cell-
cycle regulation is overly simplified in our model as opposed to the study of Powathil and col-
leagues [31] where it is in the focus of the study; cells in our model lack an explicit way to store
surplus energy as opposed to the cumulative health-factor of Swat and co-workers [30]
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representing the cells’ tolerance against starvation. Due to its 2D nature, our model is unable
to account for the out of plane transport of nutrients or cells. However, using our quasi-2D
model allows the study of several processes taking place in epithelial tissues, where most of the
tumors arise. Importantly, the implemented cellular metabolism is overly simplified to enable
the exploration of the system. After the foundation of this model framework is set out, it could
be expanded with more detailed intracellular metabolic networks, for example, using spatial
dynamic flux-balance analysis [46]. These multiscale models will lead to a tighter integration
of computational and experimental work similar to the “symbiotic” approach described in a
recent angiogenic sprouting study of Cruys and colleagues [47].
Further future work includes the more thorough exploration of different mutation rates for
different traits. One of the ultimate goals of computational systems biology is constructing a
virtual tissue in order to predict efficient treatment of various diseases. This can be achieved by
adding homeostatic mechanisms to the tissues such as contact inhibition of growth, or intro-
ducing an internal energy storage as in the study of Swat and colleagues [30]. Inclusion of a
dynamic angiogenesis model (e.g. [22, 29, 48–50]) might involve exploring the roles of differ-
ent blood vessel placements, or implementing angiogenesis models already available in the
same platform. Finally, the system enables the measurement of fitness at different spatial levels
and in different (micro- and macro-) environments which could serve as a basis for exploring
evolutionary trade-offs in using computational simulations.
Conclusion
In this study we introduce an unbiased evolutionary approach to studying the evolution of
interacting tissue cells. The model includes localized source of nutrients (oxygen, glucose) and
sink for intermediate metabolites (represented by lactate in our model), and a simplified cellu-
lar metabolism including glycolysis and respiration. Cells in the model are spatially confined
and no explicit distinction is made between stromal or tumor cells. The model exhibits distinct
stages of development with an emergent evolutionary drift towards rapid growth, high glucose
consumption, and hypoxia. This is accompanied by a Warburg-effect, whereby cells become
unable to return to respiratory metabolism even at high oxygen levels. The simulated tumor
exhibits clonal expansion and eventually gives rise to similar phenotypes around each nutrient
source which then evolve independently later on. Finally, we found that the emergent rapid
growing population is highly sensitive to intermittent nutrient supply, such as caused by leaky
tortuous blood vessels.
Methods
Details of computational model
Cell volume, adhesion and chemotaxis. The CPM was introduced in the early 1990’s
[26, 51] and has evolved into a widely used computational model, applied to various phenom-
ena in developmental biology, cell biology, and tumor biology. Cells in the model are repre-
sented as domains on a regular square lattice L  Z2 with an integer spin, sð~xÞ 2 Zþ;0, on
each lattice site~x 2 L that uniquely identifies the biological cell occupying that site, with
sð~xÞ ¼ 0 identifying the extracellular region (medium). Cell movement is described as a series
of elementary steps, in which an attempt is made to copy sð~xÞ of a randomly selected site~x
into an adjacent site~x 0. The attempt is accepted with probability 1 if it decreases the value of a
globally defined Hamiltonian function, H, or with Boltzmann probability if it would increase
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the value of H:
pðsð~xÞ !~x 0Þ ¼
1 ; if DHðsð~xÞ !~x 0Þ < 0
exp
DHðsð~xÞ !~x 0Þ
m
 
; if DHðsð~xÞ !~x 0Þ  0
8
><
>:
ð1Þ
Here DHðsð~xÞ !~x 0Þ is the change in the Hamiltonian due to the attempted copy, and
μ parametrizes the noise introduced by the active motion of cells. Immobilized cells are
implemented by rejecting any copy from or into the space occupied by them
(8~x 2 Limmob _ 8~x 0 2 Limmob : pðsð~xÞ !~x 0Þ ¼ 0). The Hamiltonian function consists of the
sum of functions that describe distinct biological features:
H ¼ Hv þ Hw þHa: ð2Þ
The first term is a volume constraint responsible for maintaining a controlled cell volume
which we implemented in a novel way as:
Hv ¼
X
i
lvðiÞ
VTðiÞ
ðVðiÞ   VTðiÞÞ2: ð3Þ
Here V(i) is the volume and VT(i) is the target volume of cell i and λv(i) describes cell com-
pressibility. Our choice of the volume term differs from the originally proposed volume term
[26] as we divide λv(i) with the target volume of the cell. Using the original formulation results
in a synchronization of cell divisions in a compressed monolayer of cells. Using our novel for-
mulation, the daughter cells after a cell division are less compressible than the mother, and
thus a cell division does not trigger a wave of divisions by allowing the neighbors to expand
more. Note that in a homogeneous population of cells (i.e., 8i 2 Zþ : VTðiÞ ¼ c, with c a con-
stant) this formulation is equivalent to the original one.
The second term represents chemotaxis and is used to calculate a chemotactic bias for the
change in the Hamiltonian as introduced by Savill and Hogeweg [52]:
DHwðsð~xÞ !~x 0Þ ¼
X
s2fO2 ;g;lg
wsðsð~x
0Þ   sð~xÞÞ ð4Þ
The function sð~xÞ represents the concentration of oxygen (O2ð~xÞ) glucose (gð~xÞ) or lactate
(lð~xÞ) at lattice site~x, and χs is the corresponding chemotactic coefficient. Diffusing chemicals
are modeled with partial-differential equations, which are solved numerically on a grid match-
ing with the grid of the CPM (see below).
For modeling cell-cell adhesion, the interactions are separated into surface-tension related
adhesion and adhesion-molecule related adhesion [53], and are described by the last term of
Eq 2 as:
Ha ¼
X
ð~x ;~x 0Þ
ð1   dð~x;~x 0ÞÞJeffðsð~xÞ; sð~x 0ÞÞ ð5Þ
where
Jeffðsð~xÞ; sð~x 0ÞÞ ¼ Jeffði; i0Þ
¼ JðtðiÞ; tði0ÞÞ  
X
a;b
ka;b min½raðiÞ; rbði0Þ
ð6Þ
and ð1   dð~x;~x 0ÞÞ ¼ 0 if the sites~x,~x 0 belong to the same cell, and 1 otherwise. Above the sim-
plified notation i ¼ sð~xÞ and i0 ¼ sð~x 0Þ is used for brevity. J(τ(i), τ(i0)) is the surface tension
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related adhesion coefficient between cell-types τ(i) and τ(i0) present at positions~x and~x 0. As J
(τ(i), τ(i0)) is typically positive, cells tend to minimize their surface area with other cells or the
medium, making the adhesion term equivalent to surface tension [51]. Three cell types are
used in the simulations: (stromal) cells, endothelial cells, and (cell-free) medium; these will be
annotated as: τ(i) 2 {c, EC, m}, respectively. The second term of Jeff in Eq 6 describes the adhe-
sion molecule related part of adhesion. The matrix ka, b defines the adhesion coefficient
between adhesion molecule type a and b, and ρa(i) represents the density of molecule a on cell
i. Therefore, the maximum amount of adhesion related to adhesion molecules a and b between
cells i and i0 is determined by min[ρa(i), ρb(i0)]. In our model, we chose the following specific
adhesions between the existing cell types:
JeffðijtðiÞ¼c; i0jtði0Þ¼cÞ ¼ Jðc; cÞ   kCAM;CAM  min ½rCAMðiÞ; rCAMði0Þ
JeffðijtðiÞ¼c; i0jtði0Þ¼ECÞ ¼ Jðc;ECÞ   kCAM;CAM  min ½rCAMðiÞ; rCAMði0Þ
JeffðijtðiÞ¼c; i0jtði0Þ¼mÞ ¼ Jðc;mÞ   kMAM;MAS  min ½rMAMðiÞ; rMASði0Þ
ð7Þ
Here CAM, MAM and MAS represent general “cell adhesion molecules”, “matrix adhesion
molecules” and “matrix adhesion sites”. CAM and MAM are expressed in cells but not the
medium. MAS are expressed on medium (matrix) on which cells are allowed to adhere. In our
simulations all the values of ka, b listed above have the value 1, the rest of the ka, b matrix is set
to 0.
The usual time measure in the CPM is the Monte Carlo Step (MCS). One MCS is defined as
N copy attempts, where N is the number of lattice sites in the grid. This choice ensures that on
average all sites are updated in every MCS, decoupling the system size and the number of
copy-attempts needed to update the whole configuration.
Metabolism. We implemented the following cellular metabolism system into the model.
Cells use glucose and oxygen to produce internal energy that is used for the production of
biomass and for supporting basal metabolism. In this section we describe how a cell produces
energy from nutrients.
Metabolites in the model are represented by the concentration fields of glucose, oxygen,
and lactate, which diffuse and decay as:
dgð~x; tÞ
dt
¼ Dgr2gð~x; tÞ   oggð~x; tÞ þ Tgðsð~xÞ; tÞ
dO2ð~x; tÞ
dt
¼ DO2r
2oð~x; tÞ   oO2O2ð~x; tÞ þ TO2ðsð~xÞ; tÞ
dlð~x; tÞ
dt
¼ Dlr2lð~x; tÞ   ollð~x; tÞ þ Tlðsð~xÞ; tÞ
ð8Þ
Here Ds is the diffusion coefficient and ωs is the decay constant of the respective species and Ts
describes the uptake or secretion of the chemical species according to boundary conditions
(in ECs) and cellular metabolism. To ensure the desired trafficking of metabolites, we imple-
mented cellular uptake of glucose and oxygen (sink) and secretion of lactate (source) while
cells metabolize as described below. To simulate the diffusion process, the above fields are rep-
resented on the same lattice used for representing cells with periodic boundary conditions.
Fields in functioning (active) blood vessel cells (ECs) are set as:
8~x 2 LEC : gð~xÞ ¼ 1 ^ O2ð~xÞ ¼ 1 ^ lð~xÞ ¼ 0, to represent the supply of glucose and oxygen
and the removal of lactate. Non-functional (inactive) ECs do not alter nutrient levels. We
implemented nutrient switching as follows: at every MCS each EC switches between active and
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inactive states with a switching probability P. Setting P ¼ 0:5 results in a frequent switching
between active and inactive states providing a reliable steady nutrient supply. Lowering P
increases the length of inactive and active states, leading to a more unreliable nutrient supply.
This way P can alter the nutrient supply stability. A stable nutrient supply represents a normal
vasculature, whereas tortuous neo-vascular vessels are blocked (inactivated) and unblocked
(activated) with a higher variation. Here we relate the amount of tortuosity to the frequency of
fluctuations in blood vessel function. Activation (unblocking) and inactivation (blocking) of
ECs occur with the same probability, therefore simulations with different blocking frequencies
P have the same average open and blocking times of blood vessels, and hence the same total
amount of nutrients over time.
We implemented two different modes in which cells are able to use the nutrients,
mimicking aerobic glycolysis and respiration of biological cells. Briefly, glucose is first
degraded into two pyruvates which generates two ATPs. The pyruvate might be converted
enzymatically to lactate (glycolysis) without further energy gain, or the cell might degrade it
using oxidative phosphorylation (respiration) to gain αr number of ATP molecules per glucose
molecule (αr> 2).
In the model, cells take up glucose through GLUT transporters using a Michaelis-Menten-
like dynamics with cell- and time-specific constants: for cell i at time t the maximum rate is
denoted as Vm(i, t) and the Michaelis-Menten constant is denoted as K(i, t). The uptake of glu-
cose from the environment at position~x per unit time is given by:
ugð~x; tÞ ¼
NGði; tÞ
Sði; tÞ
 

Vmði; tÞgð~x; tÞ
Kði; tÞ þ gð~x; tÞ
 
ð9Þ
Again, i ¼ sð~xÞ. Here g(x, t) is the extracellular glucose concentration at point~x and time t,
NG(i, t) is the number of glucose transporters (in arbitrary units) on the surface of cell i, and S
(i, t) is the cell’s surface (assuming homogeneous GLUT distribution). We implemented the
total amount of glucose taken up by cell i in each MCS as the sum of uptakes over the cell sur-
face:
Ugði; tÞ ¼
X
~x 02Sði;tÞ
ugð~x
0; tÞ
¼ NGði; tÞ
Vmði; tÞgiðtÞ
Kði; tÞ þ giðtÞ
ð10Þ
where giðtÞ ¼
P
~x 02Sði;tÞgð~x
0; tÞ is the total amount of glucose at the surface of cell i (i ¼ sð~xÞ).
A part of the glucose, denoted by h(i, t) for cell i at time t, is used only in glycolysis to pro-
duce 2 lactate molecules and 2 ATP molecules per glucose molecule (0 h(i, t) 1). The rest
of the glucose (1 − h(i, t)) is directed to oxidative phosphorylation after glycolysis to produce
αr ATP molecules per 1 glucose molecule in total. Respiration requires 6 oxygen molecules per
1 glucose molecule, and produces reactive oxygen species (ROS, z(i, t) in cell i at time t) as a
side-product. Therefore in our implementation the uptake of oxygen is determined by the
uptake of glucose and the ratio h(i, t):
uO2ð~x; tÞÞ ¼ 6ð1   hði; tÞÞugð~x; tÞ ð11Þ
at every point~x of the surface of cell i ¼ sð~xÞ at time t. Here we use the experimental results of
Subczynski and colleagues [54], who showed that oxygen permeability cannot represent a con-
straint to cellular respiration. Thus, we assume that the internal and external oxygen concen-
trations equilibrate much faster than the metabolic processes that use internal oxygen. We
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implemented the energy gain of cell i at time t as the sum of energy produced by fermentation
and respiration, minus the cost of basal metabolism:
DEði; tÞ ¼ ð2hði; tÞ þ arð1   hði; tÞÞÞUgði; tÞ   EmDt ð12Þ
where Em Δt represents the basal metabolic cost for the cell during a time interval Δt, and is
considered to be a fixed constant in the model. Therefore, the variable h(i, t) describes the state
of hypoxia in the cell, similar to the transcription factor HIF1-α. If h(i, t) = 0, the cell is using
all the glucose in the oxidative phosphorylation cycle. If h(i, t) = 1, respiration is completely
blocked and the cell changes into a state of complete fermentation in which all glucose is
turned over into lactate. In order to compensate for the reduced efficiency in energy produc-
tion in a controlled manner, when the cell is fermenting, h(i, t) = 1, we assumed the number of
glucose transporters is upregulated as well (consistent with experimental observations [55]):
NGði; tÞ ¼ N0ði; tÞ 
ar   2
ar   ðar   2Þhði; tÞ
ð13Þ
Here N0(i, t) is the factor in the GLUT concentration that is independent of the mode of cell
metabolism, and sets the intrinsic growth signal of cell i at time t. This choice of function
describes a controlled compensation for the hypoxia, since the energy gained by cell i in a
MCS is independent of the mode of metabolism, h(i, t). Substituting from Eqs 12, 10 and 13:
@DEði; tÞ
@hði; tÞ
¼
@
@hði; tÞ
ðð2   arÞhði; tÞ þ arÞ 
N0ði; tÞðar   2Þ
ar   ðar   2Þhði; tÞ

Vmði; tÞgiðtÞ
Kði; tÞ þ giðtÞ
þ EmDt
 
¼
@
@hði; tÞ
N0ði; tÞðar   2ÞVmði; tÞgiðtÞ
Kði; tÞ þ giðtÞ
þ EmDt
 
¼ 0
ð14Þ
The amount of NG(i, t) is calculated based on gi(t), the average available glucose concentra-
tion over the whole cell surface (before consumption), as the amount of NG is controlled by the
cell as a whole. We set a maximum surface density limit on the GLUT molecules, by limiting
parameter N0(i, t) to a fixed value.
The hypoxia inducible factor, HIF1-α, is induced if the level of oxygen is low in the cell:
under normal circumstances PHDs (prolyl hydroxylase) combine with oxygen and inactivate
HIF1-α [56]. When oxygen is low, the degradation of HIF1-α is slower, allowing an increase in
HIF1-α levels, leading to the reduction of respiration and therefore oxygen use. Furthermore,
HIF1-α is stabilized by the reactive oxygen species (ROS) produced in the mitochondrial respi-
ratory cycle in biological cells, creating a negative feedback to downregulate respiration if too
much ROS is present [56]. To model these dependencies, we implement h(i, t) as a function of
intracellular ROS (z(i, t)) and average oxygen level in the cell using a combination of Hill func-
tions:
hði; t þ 1Þ ¼ hðzði; tÞ; hO2iði; tÞÞ
¼ 1  
hO2iði; tÞ
nhði;tÞ
khði; tÞ
nhði;tÞ þ hO2iði; tÞ
nhði;tÞ
" #
 1  
zði; tÞnzði;tÞ
kzði; tÞ
nzði;tÞ þ zði; tÞnzði;tÞ
" #
ð15Þ
Here κ(i, t) and n(i, t) are parameters describing the threshold and sensitivity of the switch to
the levels of ROS (z(i, t)) and average oxygen level (hO2i(i, t)) in cell i at time t. Note that the
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value of h(i, t) in the cell is calculated from values of ROS and oxygen within the cell at the pre-
vious time step t. This time delay is natural, as the signaling is not expected to instantly alter
the biochemical state of the cell. Finally, the level of ROS is increased by the amount of glucose
processed in mitochondrial respiration in the previous time step, and the previous values of
ROS in the cell:
zði; t þ 1Þ ¼ ð1   hði; tÞÞUgði; tÞ   ozzði; tÞ ð16Þ
where ωz is the decay constant of the ROS inside the cell.
Cell growth. In every time step, the cell is allowed to use its energy to produce biomass,
by increasing its target volume VT(i, t) as:
VTði; t þ DtÞ ¼ VTði; tÞ þ
@VTði; tÞ
@t
Dt ð17Þ
with:
@VTði; tÞ
@t
¼ a  ðEði; tÞ   EmÞ   b
ðVði; tÞ   VTði; tÞÞ3
jVði; tÞ   VTði; tÞj
  gYðzði; tÞ   yRði; tÞÞ ð18Þ
where α is a growth rate parameter, describing the efficiency of anabolism: biomass produced
per unit of energy per unit of time, and Em is the energy lost for the basal metabolism per time
step (Δt). The second term expresses a tendency of a model cell to reduce its intracellular den-
sity fluctuations: If a cell is compressed, its growth is decreased. The third term expresses the
effect of ROS (z) on cell growth. High levels of ROS are toxic for the cell (interferes with pro-
tein folding), forcing the model cell to reduce in size. The function Θ is the Heaviside step-
function and θR(i, t) is a threshold for ROS levels that a cell can tolerate without damage. If
cells are not allowed to grow, for example due to contact inhibition of growth, then the target
volume is not increased, but is allowed to decrease.
Irrespective of whether a cell grows or not, the energy of the cell is depleted leaving the cell
with no internal energy reserve. If the produced energy in a time step is smaller than the meta-
bolic need of the cell (E(i, t) − Em), the cell’s target volume will be reduced by α  (E(i, t) − Em)
and its energy is set to zero. This way we include catabolism in our model cells, which allows
them to use their target volume as a type of internal energy storage.
Cells divide if their size (V(i, t)) is around division size VD(i, t). The probability of allowing
cell division is defined by a sigmoid function:
PsizeðdivÞ ¼
0 ; if Vði; tÞ < VDði; tÞ   3w
Vði; tÞ   VDði; tÞ
2
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
w2 þ ðVði; tÞ   VDði; tÞÞ
2
q þ
1
2
; if VDði; tÞ   3w  Vði; tÞ < VDði; tÞ þ 3w
1 ; if VDði; tÞ þ 3w  Vði; tÞ
ð19Þ
8
>
>
>
<
>
>
>
:
Here w is a parameter setting the width of the fuzzy threshold, and is set to the 5% of the divi-
sion size: w = 0.05VD(i, t). Upon division, the mother cell divides, and its biomass (VT(i, t)) is
shared equally between the two daughter cells.
To maintain cell turnover, cells are selected for apoptosis at a constant probability (0.1%
per cell per MCS). When a cell is selected for apoptosis, its target volume is decreased with a
constant rate until it reaches zero. At that point the cell is removed from the simulation and its
volume is converted into extracellular space.
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Evolution in the model. We implemented evolution in the model as follows. To mimic
plasticity, a set of cellular parameters are tested independently for mutation in daughter cells.
Such a parameter p is allowed to change with a probability (mutation rate μp). The new value
for the parameter is drawn from a normal distribution centered at the previous value, and with
a standard deviation determined by the characteristic step size parameter σp of the mutation
for each parameter: p0 = p + ξ(σp), where ξ(σp) is drawn from the normal distribution N ð0; s2pÞ.
The parameter values are bound in within a pre-set parameter range, with reflective bound-
aries (see Fig 1b). Constructed this way, the cells perform a random walk in the parameter
space through mutations as they progress from generation to generation.
The cellular parameters that are allowed to undergo such mutation are controlling the phys-
ical properties of the cells (compressibility through λv, division size VD), adhesion properties
(ρCAM(c), ρMAM(c)), chemotaxis sensitivities (χg, wO2 , χl), growth (through N0), and metabolism
(sensitivity thresholds κh, κz). Values for these parameters are summarized in Table 1.
Initial conditions
Cells are initialized in a monolayer with an initial volume and target volume of 25 lattice sites
on a lattice of 200 × 200 and four endothelial cells (Fig 1a). In the initial regime of the simula-
tions, nutrients are allowed to diffuse into the system to obtain a natural distribution resulting
in high glucose and oxygen and low lactate levels (Fig 1b). During this equilibrating time cells
are allowed to metabolize, but cannot grow, shrink, move, or mutate. This state represents a sta-
ble, homeostatic tissue with sufficient nutrient availability. When the temporal changes in dif-
fusing nutrients is less than 5% in a time interval of 100 MCS, the initial regime is closed, cells
are released and the simulation is started. Nutrient fields at the beginning of the initial regime
(Fig 1b) are initialized using pre-generated concentration distributions to expedite equilibra-
tion. These initial concentration fields are generated by simulating a cell population in the ini-
tial regime starting with zero concentrations: 8~x 2 L : gð~x; t ¼ 0Þ ¼ 0, O2ð~x; t ¼ 0Þ ¼ 0,
lð~x; t ¼ 0Þ ¼ 0. The concentration fields are saved when the total concentration levels remain
within 5% over a 100 MCS iteration period:
P
x~ðsð~x; t ¼ tsaveÞ   sð~x; t ¼ tsave   100MCSÞÞ <
0:05
P
x~sð~x; t ¼ tsave   100MCSÞ for s 2 {g, O2}. Note that no lactate is present as all cells are
respiratory in the initial regime. All mutating parameters in all cells are initialized with the
same value, after which all cells undergo a mutation attempt to provide an initial heterogeneity
to the population.
Adhesion parameters are set to J(c, c) = J(c, EC) = Jmax, and J(c, m) = Jmax/2 for the three
region (“cell”) types: stromal cells (c), endothelial cells (EC), and cell-free areas (m). To allow
the full range of interactions for cells, we fix the adhesion molecule density values of the extra-
cellular region and the endothelial cells as:
kCAM;CAM  rCAMðijtðiÞ:ECÞ ¼ Jðc;ECÞ ¼ Jmax
kMAM;MAS  rMASðijtðiÞ:mÞ ¼ Jðc;mÞ ¼ Jmax=2
ð20Þ
With this choice the effective Jeff values are allowed to change between 0 and Jmax for Jeff(c, c),
and Jeff(c, EC). For interaction with the medium, Jeff(c, m) is allowed to change between 0 and
Jmax/2.
Diffusion parameters for glucose, oxygen, and lactate were set to Dg = 10−9 m2/s and
DO2 ¼ Dl ¼ 10
  11m2=s following the approximation of Jiang and coworkers [40], and decay is
neglected for all of these chemical species (ωs = 0, s 2 {g, O2, l}). Decay rate of ROS is set to a
constant ωz = 0.1 per MCS. The amount of ATP produced from 1 glucose molecule through
respiration was chosen as αr = 38. This approximation is a theoretical upper limit for the
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process, in reality this number is expected to be lower. However, due to the compensation
with the number of glucose transporters (see Eq 13) the exact value of this parameter is not
expected to change the behavior of the system.
Parameter analysis
To analyze the population behavior over the simulations we analyzed the evolving parameters
in the following way. For every parameter p(i, t) of cell i at time t we calculated a normalized
parameter as pn(i, t) = [p(i, t) − p(i, t = 0)]/σp where σp is the characteristic step size of the
parameter. This way the normalized parameters reflect their distance from their origin in
terms of mutational step-size. The distribution of cell phenotypes in this space was analyzed at
time t by finding the principal components of the 10-dimensional set of pn(i, t) points for all i
and p using singular value decomposition from scientific python (SciPy). The axes correspond-
ing to the first three largest eigenvalues were selected as the main components of the cloud.
Clustering in the normalized phenotype space was performed using hierarchical clustering
of SciPy with the Ward method and Euclidean distances. To distinguish clusters we established
a cutoff cophenetic distance of 100 manually by evaluating a set of selected dendograms and
distribution of clusters plotted on the first three main axes. Displacement of the clusters is cal-
culated as the (10D) Euclidean distance of the center of mass of the cluster from its initial
point of origin. Spread of clusters was calculated as the mean distance of points in the cluster
from its center of mass. Density of clusters was calculated by dividing the spread by the num-
ber of points in the cluster.
Supporting information
S1 Fig. Phenotypic behavior of simplified models with one (N0) or four (N0, χg, wO2 , χl)
mutable cellular parameters is similar to behavior of full model. (a) Nutrient levels and
number of cells in the simplified models; compare with Fig 3d. (b) Patches of high growth simi-
lar to those in the full model shown by the instantaneous growth rate and generation number of
cells as in Fig 4e and 4f. (c) Hypoxia and ROS in the simplified models; compare with Fig 4l. (d)
Oxygen and glucose consumption in the simplified models; compare with Fig 4m. Population
averages from 10 independent simulation runs with standard deviation across simulations.
(TIF)
S2 Fig. Effect of mutation rate on population size and stage progression. Average number
of cells and nutrient concentrations in simulations with mutation rates of 20% (a), 30% (b),
40% (c), 50% (d), 60% (e), 70% (f), 80% (g), and 90% (h). Progress of populations through
stages is increasing with increasing mutation rates. Population averages from 10 independent
simulation runs with standard deviation across simulations. (i) Relative weight (eigenvalues)
of the principal axes of populations in phenotype space averaged from 10 independent simula-
tion runs for 1%, 10%, and 20% mutation rates each. (j) Averaged composition of the first
three principal axes in the populations shown in (i).
(TIF)
S3 Fig. Effect on fluctuating nutrient supply on populations with mutation rate μ = 0.1%.
Hypoxia (a), ROS (b), cellular pressure (c), and chemotaxis towards oxygen (d) glucose (e) and
lactate (f), remain largely unaffected by different vessel blocking probabilities. Note that the
variation increases with lower blocking probability P due to fewer surviving cell populations.
Population averages from 10 independent simulation runs with standard deviation across sim-
ulations. Blocking probability values P show on graphs.
(TIF)
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S1 File. Script and code for running simulations of the model using the CompuCell3D
framework (ZIP). Simulations were run using a CompuCell3D installation available from the
Indiana University Bloomington and the Biocomplexity Institute (www.compucell3d.org)
[39]. Parameters for the simulations are set in XML scripts (simulation.xml). Simulations
require initial configuration files for cells and diffusible concentration fields (PIFtemplate.pif,
FieldGLUtemplate.txt, FieldOXYtemplate.txt) specified in the XML file, and a set of customized
plugins (called ‘steppables’ and ‘plugins’) to be installed in the CompuCell3D ‘DeveloperZone’.
Simulation outputs are a set of files for each sampling time point that contain cell-based infor-
mation (values of mutating parameters and other cell-level indicators), concentration field
data, and cell configuration data.
(ZIP)
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